Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
Filip Van den Bosch(Ghent University Hospital), Eric Veys(Ghent University Hospital)
Cited by 292